Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Launches System To Track Performances of Its Offices

This article was originally published in The Tan Sheet

Executive Summary

For those wondering how many adverse events reports FDA received last month, the number of Risk Evaluation and Mitigation Strategies it cleared or the number of first generics it approved, the answers are now readily accessible
Advertisement

Related Content

FDA Congressional Relations, Internal Structure May Change With Sharfstein Exit
FDA Congressional Relations, Internal Structure May Change With Sharfstein Exit
FDA Congressional Relations, Internal Structure May Change With Sharfstein Exit
Disclosure Of NDA Filings Recommended In Transparency Report
Disclosure Of NDA Filings Recommended In Transparency Report
FDA Transparency Has No Clear Path To Releasing Documents - Woodcock
HHS Open Government Plan Includes New FDA, CMS Web Initiatives
HHS Open Government Plan Includes New FDA, CMS Web Initiatives
Information Disclosure Issues Challenge FDA Transparency Task Force
Information Disclosure Issues Challenge FDA Transparency Task Force

Topics

Advertisement
UsernamePublicRestriction

Register

PS103990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel